Viatris Inc. VTRS
Super Investor & Insider
2
Fondi che lo detengono
#414
Rank consenso
2.9%
% dei portafogli
$1.07B
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Christopher Davis · Davis Selected Advisers | 4.85% | Add 0.04% | 78,211,191 | $1.06B |
| Bill Miller · Miller Value Partners | 2.58% | Add 18.2% | 731,676 | $9.9M |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Viatris Inc. is a global healthcare company that delivers quality medicines and innovative solutions to improve health access worldwide. It offers a dynamic portfolio spanning generics, including commoditized, complex products and biosimilars, alongside globally recognized established brands such as Lipitor, Norvasc, L…
SectorHealthcare
ExchangeNASDAQ
IndustryDrug Manufacturers - Specialty & Generic
CountryUnited States
Employees30,000
TickerVTRS
Statistics
Market Cap$18.29B
Revenue (TTM)$14.30B
Net Income-$3.51B
Net Margin-24.6%
EPS$-3.00
P/E235.80
P/S1.30
P/B1.28
EV/EBITDA7.41
ROE-2.0%
Dividend Yield2.91%
Price$15.71
Data: Twelve Data · Revenue = mcap / P/S